2024 Speaker Faculty

Brandon Malone

Manager of Research & Technology Development

NEC OncoImmunity

Agnete Fredriksen

Co-Founder & Chief Buisness Officer

Nykode Therapeutics

Bruno Fant

Chief Technology Officer

myNEO Therapeutics

Nancy Groot

Director - Biopharma Business Development

Personalis

Helena Sabata

Business Development

BCN Peptides

Bauke Anninga

Investment Director

M Ventures

Giulia Longinotti

Director TCR Discovery Platform

Medigene Immunotherapies GmbH

Andrew Allen

President & Chief Executive Officer

Gritstone Bio

Maarten Slagter

Scientist Computational Cancer Genomics

CureVacSE

Jeroen Kneppers

Scientist (Computational) Cancer Genomics

CureVacSE

Jian Yan

Vice President - Research & Discovery

Geneos Therapeutics

Mark Exley

Chief Scientific Officer

Imvax

Guido Leoni

Lead of bioinformatic

Nouscom Srl

Nicolas Poirier

Chief Executive Officer

OSE Immunotherapeutics

Eric Halioua

President & Chief Executive Officer

PDC*line Pharma

Marc van Dijk

Chief Scientific Officer

MiNK Therapeutics

Eniko Toke

Chief Scientific Officer

Treos Bio Inc.

Christian Stumpp

Head of Business Development

Intavis Peptide Services GmbH

Alfred Slanetz

President & Chief Executive Officer

Geneius Biotechnology, Inc.

Jon Moore

Chief Scientific Officer & Co-Founder

Epitopea

Erkut Bahceci

Chief Medical Officer

BlueSphere Bio

Devabhaktuni Srikrishna

Neoantigen Expert

-

Martin Löwer

Deputy Director Biomarker Development

TRON

Alastair Hay

Vice President, Peptides

Almac Sciences

Dirk Hadaschik

Chief Scientific Officer

CeCaVa GmbH & CO. KG

Zelanna Goldberg

Chief Medical Officer

Replicate Bioscience

Paula Pohlmann

Associate Professor

University of Texas MD Anderson Cancer Centre

Philip Arlen

President & Chief Executive Officer

Precision Biologics Inc.

Wayne Paes

Senior Scientist

Grey Wolf Therapeutics